生鮮零售連鎖店錢大媽計劃在香港進行IPO
彭博報道稱,生鮮零售連鎖店錢大媽計劃在香港進行IPO,募資最多5億美元。
錢大媽據悉計劃在IPO前的一輪融資中籌集20億元人民幣。
錢大媽是廣州市錢大媽農產品有限公司旗下連鎖品牌,誕生於2012年,以“不賣隔夜肉”爲經營理念。天眼查顯示,錢大媽至今已完成五輪融資。業內估計,錢大媽目前估值在85億元至100億元之間。
最新一輪是D輪,2019年12月26日,錢大媽宣佈完成近10億人民幣D輪融資。該輪投資方由基石資本領投,泰康人壽、啓承資本、兼固資本、正瀚投資、光源資本跟投,其中已連續參與B、B+、C輪融資的老股東啓承資本,在本次融資中再次追投。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.